Perspectives of inclusion bodies for bio-based products: curse or blessing?
E. coli
Inclusion bodies
Process understanding
Quality attributes
Upstream processing
protein activity
Journal
Applied microbiology and biotechnology
ISSN: 1432-0614
Titre abrégé: Appl Microbiol Biotechnol
Pays: Germany
ID NLM: 8406612
Informations de publication
Date de publication:
Feb 2019
Feb 2019
Historique:
received:
10
10
2018
accepted:
07
12
2018
revised:
06
12
2018
pubmed:
21
12
2018
medline:
31
5
2019
entrez:
21
12
2018
Statut:
ppublish
Résumé
The bacterium Escherichia coli is a major host for recombinant protein production of non-glycosylated products. Depending on the expression strategy, the recombinant protein can be located intracellularly, which often leads to protein aggregates inside of the cytoplasm, forming so the called inclusion bodies (IBs). When compared to other protein expression strategies, inclusion body formation allows high product titers and also the possibility of expressing proteins being toxic for the host. In the past years, the comprehension of inclusion bodies being only inactive protein aggregates changed, and the new term of non-classical inclusion bodies emerged. These inclusion bodies are believed to contain a reasonable amount of active protein within their structure. However, subsequent downstream processing, such as homogenisation of cells, centrifugation or solubilisation of IBs, is prone to variable process performance and is often known to result in low extraction yields. It is hypothesised that variations in IB quality attributes are responsible for those effects and that such attributes can be controlled by upstream process conditions. In this review, we address the impact of process design (process parameters) in the upstream on defined inclusion body quality attributes. The following topics are therefore addressed: (i) an overview of the range of inclusion body applications (including emerging technologies); (ii) analytical methods to determine quality attributes; and (iii) screws in process engineering to achieve the desired quality attributes for different inclusion body-based applications. Process parameters in the upstream can be used to trigger different quality attributes including protein activity, but are not exploited to a satisfying content yet. Design by quality approaches in the upstream are already considered for a multitude of existing processes. Further intensifying this approach may pave the industrial application for new IB-based products and improves IB processing, as discussed within this review.
Identifiants
pubmed: 30569219
doi: 10.1007/s00253-018-9569-1
pii: 10.1007/s00253-018-9569-1
pmc: PMC6394472
doi:
Substances chimiques
Recombinant Proteins
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1143-1153Références
Biotechnol Bioeng. 1999 Oct 5;65(1):54-64
pubmed: 10440671
Eur J Biochem. 2000 May;267(10):2871-81
pubmed: 10806384
Curr Opin Biotechnol. 2001 Apr;12(2):202-7
pubmed: 11287238
J Ind Microbiol Biotechnol. 2002 Jul;29(1):34-7
pubmed: 12080425
Microb Cell Fact. 2003 Apr 9;2(1):2
pubmed: 12740045
Appl Microbiol Biotechnol. 1992 Aug;37(5):609-14
pubmed: 1369400
Appl Microbiol Biotechnol. 2005 Apr;67(2):151-9
pubmed: 15580495
Biotechnol Prog. 2005 Mar-Apr;21(2):632-9
pubmed: 15801811
J Ind Microbiol Biotechnol. 2006 Mar;33(3):173-82
pubmed: 16195870
Protein Expr Purif. 2006 Jun;47(2):621-8
pubmed: 16495080
Biotechniques. 2006 Mar;40(3):355-64
pubmed: 16568824
Appl Environ Microbiol. 2007 Jan;73(1):289-94
pubmed: 17085715
Biotechnol Appl Biochem. 2008 Apr;49(Pt 4):239-46
pubmed: 17708747
Mol Cell Biochem. 2008 Jan;307(1-2):249-64
pubmed: 17874175
Nat Methods. 2007 Dec;4(12):1037-43
pubmed: 18026112
Appl Environ Microbiol. 2008 Feb;74(4):1124-35
pubmed: 18156341
BMC Biotechnol. 2008 Jan 14;8:2
pubmed: 18194555
J Biotechnol. 2008 Mar 20;134(1-2):146-53
pubmed: 18313163
Biotechnol J. 2008 Oct;3(9-10):1245-55
pubmed: 18702088
Microb Cell Fact. 2008 Dec 01;7:34
pubmed: 19046444
Anal Biochem. 2009 Mar 15;386(2):147-55
pubmed: 19150325
FEBS Lett. 1991 Apr 22;282(1):205-8
pubmed: 2026260
Biomaterials. 2010 Aug;31(22):5805-12
pubmed: 20452667
Microb Cell Fact. 2010 May 28;9:41
pubmed: 20509924
Trends Microbiol. 2010 Sep;18(9):423-30
pubmed: 20674365
Nat Biotechnol. 2010 Sep;28(9):917-24
pubmed: 20829826
FEBS J. 2011 Jul;278(14):2419-27
pubmed: 21569209
Trends Biotechnol. 2012 Feb;30(2):65-70
pubmed: 22037492
J Biotechnol. 2012 Jan;157(1):82-8
pubmed: 22079752
J Ind Microbiol Biotechnol. 2012 Mar;39(3):383-99
pubmed: 22252444
Biotechnol Prog. 2012 Mar-Apr;28(2):421-7
pubmed: 22275283
Microb Cell Fact. 2012 Jul 04;11:46
pubmed: 22513097
Curr Protoc Protein Sci. 2012 Nov;Chapter 6:Unit6.3
pubmed: 23151747
Appl Spectrosc. 2012 Dec;66(12):1365-84
pubmed: 23231899
J Ind Microbiol Biotechnol. 2013 Apr;40(3-4):257-74
pubmed: 23385853
Nanomedicine (Lond). 2013 Oct;8(10):1587-99
pubmed: 23394133
Trends Biotechnol. 2014 Jan;32(1):54-60
pubmed: 24183828
Front Microbiol. 2014 Feb 14;5:56
pubmed: 24592259
J Bacteriol. 2014 Jul;196(13):2325-32
pubmed: 24633872
Aust J Biotechnol. 1989 Jan;3(1):28-32
pubmed: 2485330
Microb Cell Fact. 2014 Sep 12;13:137
pubmed: 25213001
Microb Cell Fact. 2014 Oct 02;13:141
pubmed: 25270715
Nat Biotechnol. 2014 Oct;32(10):992-1000
pubmed: 25299917
Methods Mol Biol. 2015;1258:411-22
pubmed: 25447879
J Microbiol Biotechnol. 2015 Jul;25(7):953-62
pubmed: 25737124
World J Microbiol Biotechnol. 2015 May;31(5):681-90
pubmed: 25792298
Microb Cell Fact. 2015 Mar 25;14:41
pubmed: 25889252
Microb Cell Fact. 2015 Jun 16;14:88
pubmed: 26077447
Nanomedicine (Lond). 2015;10(18):2881-91
pubmed: 26370294
Res Pharm Sci. 2015 Jan-Feb;10(1):75-83
pubmed: 26430460
Microb Cell Fact. 2015 Dec 21;14:201
pubmed: 26691337
Appl Microbiol Biotechnol. 2016 Oct;100(20):8721-9
pubmed: 27229726
Crit Rev Microbiol. 2017 Feb;43(1):31-42
pubmed: 27387055
Metab Eng. 2017 Mar;40:41-49
pubmed: 28038953
Biotechnol J. 2017 Jul;12(7):null
pubmed: 28120503
Trends Biochem Sci. 2017 Sep;42(9):726-737
pubmed: 28254353
J Biotechnol. 2017 Apr 20;248:15-24
pubmed: 28288816
Biotechnol J. 2017 Jun;12(6):null
pubmed: 28301074
Microb Cell Fact. 2017 Mar 21;16(1):50
pubmed: 28320377
Sci Rep. 2017 Mar 23;7:45072
pubmed: 28332595
Appl Microbiol Biotechnol. 2018 Jan;102(2):667-676
pubmed: 29159587
Bioengineering (Basel). 2017 Dec 21;5(1):null
pubmed: 29267215
Microb Cell Fact. 2018 Sep 20;17(1):148
pubmed: 30236107
World J Microbiol Biotechnol. 2018 Oct 19;34(11):158
pubmed: 30341583
Proc Natl Acad Sci U S A. 1973 Nov;70(11):3240-4
pubmed: 4594039
FEMS Microbiol Rev. 1994 May;14(1):99-102
pubmed: 8011364
J Biol Chem. 1996 May 10;271(19):11141-7
pubmed: 8626659